These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 22936102)
1. Cryptococcus laurentii biofilms: structure, development and antifungal drug resistance. Ajesh K; Sreejith K Mycopathologia; 2012 Dec; 174(5-6):409-19. PubMed ID: 22936102 [TBL] [Abstract][Full Text] [Related]
2. Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro. Martinez LR; Casadevall A Antimicrob Agents Chemother; 2006 Mar; 50(3):1021-33. PubMed ID: 16495265 [TBL] [Abstract][Full Text] [Related]
3. Temperature affects the susceptibility of Cryptococcus neoformans biofilms to antifungal agents. Pettit RK; Repp KK; Hazen KC Med Mycol; 2010 Mar; 48(2):421-6. PubMed ID: 19637092 [TBL] [Abstract][Full Text] [Related]
4. Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-t etrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for susceptibility to antifungal agents. Hawser SP; Norris H; Jessup CJ; Ghannoum MA J Clin Microbiol; 1998 May; 36(5):1450-2. PubMed ID: 9574729 [TBL] [Abstract][Full Text] [Related]
5. Histoplasma capsulatum in planktonic and biofilm forms: in vitro susceptibility to amphotericin B, itraconazole and farnesol. Brilhante RSN; de Lima RAC; Marques FJF; Silva NF; Caetano ÉP; Castelo-Branco DSCM; Bandeira TJPG; Moreira JLB; Cordeiro RA; Monteiro AJ; Camargo ZP; Sidrim JJC; Rocha MFG J Med Microbiol; 2015 Apr; 64(Pt 4):394-399. PubMed ID: 25657300 [TBL] [Abstract][Full Text] [Related]
6. Fungaemia due to Cryptococcus laurentii and a review of non-neoformans cryptococcaemia. Johnson LB; Bradley SF; Kauffman CA Mycoses; 1998; 41(7-8):277-80. PubMed ID: 9861831 [TBL] [Abstract][Full Text] [Related]
7. Fungemia in a cancer patient caused by fluconazole-resistant Cryptococcus laurentii. Averbuch D; Boekhoutt T; Falk R; Engelhard D; Shapiro M; Block C; Polacheck I Med Mycol; 2002 Oct; 40(5):479-84. PubMed ID: 12462527 [TBL] [Abstract][Full Text] [Related]
8. In vitro effects of ambroxol on Cryptococcus adherence, planktonic cells, and biofilms. Kong Q; Du X; Huang S; Yang R; Zhang C; Shen Y; Liu W; Sang H APMIS; 2017 Jul; 125(7):634-640. PubMed ID: 28444776 [TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibility to antifungal agents of environmental Cryptococcus spp. isolated in the city of Ribeirão Preto, São Paulo, Brazil. Pedroso RS; Ferreira JC; Candido RC Mem Inst Oswaldo Cruz; 2006 May; 101(3):239-43. PubMed ID: 16862315 [TBL] [Abstract][Full Text] [Related]
11. Repeated isolation of Cryptococcus laurentii from the oropharynx of an immunocompromized patient. Bauters TG; Swinne D; Boekhout T; Noens L; Nelis HJ Mycopathologia; 2002; 153(3):133-5. PubMed ID: 11998874 [TBL] [Abstract][Full Text] [Related]
12. In vitro efficacy of eugenol in inhibiting single and mixed-biofilms of drug-resistant strains of Candida albicans and Streptococcus mutans. Jafri H; Khan MSA; Ahmad I Phytomedicine; 2019 Feb; 54():206-213. PubMed ID: 30668370 [TBL] [Abstract][Full Text] [Related]
13. Activity of 3'-hydroxychalcone against Cryptococcus gattii and toxicity, and efficacy in alternative animal models. Palanco AC; Lacorte Singulani J; Costa-Orlandi CB; Gullo FP; Strohmayer Lourencetti NM; Gomes PC; Ayusso GM; Dutra LA; Silva Bolzani VD; Regasini LO; Soares Mendes-Giannini MJ; Fusco-Almeida AM Future Microbiol; 2017 Oct; 12():1123-1134. PubMed ID: 28876122 [TBL] [Abstract][Full Text] [Related]
14. The use of chitosan to damage Cryptococcus neoformans biofilms. Martinez LR; Mihu MR; Han G; Frases S; Cordero RJ; Casadevall A; Friedman AJ; Friedman JM; Nosanchuk JD Biomaterials; 2010 Feb; 31(4):669-79. PubMed ID: 19819009 [TBL] [Abstract][Full Text] [Related]
15. Addition of DNase improves the in vitro activity of antifungal drugs against Candida albicans biofilms. Martins M; Henriques M; Lopez-Ribot JL; Oliveira R Mycoses; 2012 Jan; 55(1):80-5. PubMed ID: 21668524 [TBL] [Abstract][Full Text] [Related]
16. Emergence of amphotericin B-resistant Cryptococcus laurentii meningoencephalitis shortly after treatment for Cryptococcus neoformans meningitis in a patient with AIDS. Manfredi R; Fulgaro C; Sabbatani S; Legnani G; Fasulo G AIDS Patient Care STDS; 2006 Apr; 20(4):227-32. PubMed ID: 16623620 [TBL] [Abstract][Full Text] [Related]
17. Cell density and cell aging as factors modulating antifungal resistance of Candida albicans biofilms. Seneviratne CJ; Jin LJ; Samaranayake YH; Samaranayake LP Antimicrob Agents Chemother; 2008 Sep; 52(9):3259-66. PubMed ID: 18625775 [TBL] [Abstract][Full Text] [Related]
18. First report of Cryptococcus laurentii meningitis and a fatal case of Cryptococcus albidus cryptococcaemia in AIDS patients. Kordossis T; Avlami A; Velegraki A; Stefanou I; Georgakopoulos G; Papalambrou C; Legakis NJ Med Mycol; 1998 Oct; 36(5):335-9. PubMed ID: 10075504 [TBL] [Abstract][Full Text] [Related]